THE USE OF TIAGABINE FOR TREATMENT OF DIABETIC NEUROPATHY AND MIGRAINE

Title:

THE USE OF TIAGABINE FOR TREATMENT OF DIABETIC NEUROPATHY AND MIGRAINE

Document Type and Number:

WIPO Patent Application WO2002038144

Kind Code:

A8

Abstract:

(R)-N-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid and salts thereof are effective GABA uptake inhibitory compounds and exert pharmacological effects on pain associated with diabetic neuropathy and migraine.

More Like This:

JP6150777	The process for solid pharmacological constituents and those production
JP5714492	Granules, how to prepare them, and pharmaceuticals containing them

Inventors:

COLLINS STEPHEN D
DEATON ROGER L
GIARDINA WILLIAM J
GILBERT ADRIENNE L

Application Number:

PCT/US2001/051407

Publication Date:

July 11, 2002

Filing Date:

October 19, 2001

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ABBOTT LAB (US)

International Classes:

A61K9/20; A61K31/4535; A61P25/04; A61P25/06

Download PDF:

View/Download PDF PDF Help

Previous Patent: ENHANCED EFFICACY AND SAFETY OF GENOTOXIC THERAPY BY P38 MAPK MODULATION

Next Patent: COMPOSITIONS AND METHODS FOR SEDATING, ANAESTHETISING AND EUTHANASING AQUATIC ORGANISMS